GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,452,000 | -41.1% | 33,337 | -41.1% | 0.01% | -27.3% |
| Q1 2022 | $2,466,000 | +7.7% | 56,619 | +9.1% | 0.01% | +83.3% |
| Q4 2021 | $2,289,000 | +110.4% | 51,914 | +90.0% | 0.01% | +50.0% |
| Q2 2021 | $1,088,000 | -40.4% | 27,318 | -46.6% | 0.00% | -63.6% |
| Q1 2021 | $1,826,000 | -57.7% | 51,149 | -56.4% | 0.01% | -65.6% |
| Q4 2020 | $4,317,000 | +419.5% | 117,312 | +431.4% | 0.03% | +190.9% |
| Q3 2020 | $831,000 | -35.1% | 22,076 | -34.6% | 0.01% | -66.7% |
| Q1 2020 | $1,280,000 | -70.4% | 33,780 | -63.3% | 0.03% | +26.9% |
| Q4 2019 | $4,328,000 | +816.9% | 92,115 | +733.3% | 0.03% | +550.0% |
| Q3 2019 | $472,000 | -75.5% | 11,054 | -77.1% | 0.00% | -78.9% |
| Q2 2019 | $1,928,000 | -6.0% | 48,175 | -1.9% | 0.02% | -13.6% |
| Q1 2019 | $2,052,000 | – | 49,114 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |